Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged High-Dose Stimulants in Methamphetamine Use Disorder
NCT06788587Phase 2Recruiting
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Jul 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisdexamfetamine in methamphetamine use disorder (MUD), sponsored by Centre hospitalier de l’Université de Montréal. Started Jul 2025; status: recruiting.
02
Drugs
lisdexamfetamine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT06788587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06788587.